Source: Annual Congress 2004 - Longitudinal studies and determinants of lung function and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Chambellan, E. Chailleux, T. Similowski, the ANTADIR Observatory (Nantes, Paris, France). Prognostic value of a low hematocrit in COPD: a 20-year study of the ANTADIR observatory. Eur Respir J 2004; 24: Suppl. 48, 2685

Member's Comments

No comment yet.

Related content which might interest you: Prognostic value of hematocrit in chronic respiratory insufficiency – a 20-year analysis of the ANTADIR observatory Source: Eur Respir J 2006; 28: Suppl. 50, 68s Year: 2006 Prognostic value of symptoms at lung cancer diagnosis: a two-year observational study Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 COPD and microalbuminuria: a 12-year follow-up study Source: Eur Respir J 2014; 43: 1042-1050 Year: 2014 Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 The Rotterdam study: why fall in COPD? Source: Eur Respir J 2015; 46: 1530-1531 Year: 2015 The Rotterdam study: why fall in COPD? Source: Eur Respir J 2015; 46: 1529-1530 Year: 2015 A 20-year follow-up of a population study-based COPD cohort Source: Annual Congress 2010 - Highlights of longitudinal, geographical and time trend studies of asthma and COPD Year: 2010 Comparative analysis of asthma and COPD incidence in Serbia - a 10-year period Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002 Stability of FENO50 in a COPD cohort in Sweden over 2-year follow-up Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020 Year: 2021 An epidemiological study of chronic obstructive pulmonary disease (COPD) in a rural town of Japan: a one-year follow-up study Source: Eur Respir J 2006; 28: Suppl. 50, 448s Year: 2006 Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study Source: Eur Respir J 2002; 20: 539-544 Year: 2002 Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020 Year: 2021 Late Breaking Abstract - Optimizing FEV1/FVC threshold to predict COPD hospitalization and mortality: NHLBI pooled cohorts study Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Should we use FEV1/FVC <0.70 or FEV1/FVC <LLN to identify subjects with a clinical history indicating COPD – Results from the population-based BOLD study in Salzburg, Austria Source: Annual Congress 2011 - COPD diagnosis Year: 2011 Predictive value of fibrinogen/D-dimer ratio in patients with pulmonary embolism: a retrospective study Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Eosinophil count on admission is not a good biomarker in severe exacerbations of COPD to predic later readmission: a long term observational study from the AECOPD-Barcelona Cohort Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018